|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-03
|
$1,902,504
|
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
The 3D whole Body Distribution of NIR transferrin using FRET tomography imaging
|
1R21CA161782-01
|
$178,809
|
|
BARROSO, MARGARIDA
|
ALBANY MEDICAL COLLEGE
|
|
Tumor microenvironments determing migration, dissemination and dormancy
|
1U54CA163131-01
|
$838,472
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EMT, Extravasation and metastasis by N-Cadherin signaling
|
3R01CA135061-03S1
|
$68,792
|
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Health-Seeking Behaviors among Men with Criminal Justice and Substance Abuse Hist
|
5K01CA154861-02
|
$130,185
|
|
Valera, Pamela
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
|
1R01CA164468-01
|
$799,600
|
|
Verkhusha, Vladislav
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
RTOG Tissue Bank
|
3U24CA114734-05S2
|
|
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American Psychosocial Oncology Society Annual Conference: Integrating Psychosocia
|
5R13CA138133-03
|
$20,000
|
|
BADGER, TERRY
|
AMERICAN PSYCHOSOCIAL ONCOLOGY SOCIETY
|
|
Tpl2 in Carcinogenesis-Related Inflammation
|
1UA5CA152907-01A1
|
$380,871
|
|
DeCicco-Skinner, Kathleen
|
AMERICAN UNIVERSITY
|
|
TOPIC 293, Phase I, POINT OF CARE DEVICE FOR ANTIBODY INDEPENDENT ISOLATION OF CI
|
N43CO110114-000
|
$198,812
|
|
DAVIS, DARREN
|
APOCELL, INC.
|
|
A Center for the Convergence of Physical Science and Cancer Biology
|
4U54CA143862-03
|
$1,715,390
|
|
Davies, Paul
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Storytelling for Colorectal Health among Latinos
|
5R01CA118663-05
|
$469,333
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Live-cell Microarray for high-throughput observation of metabolic signatures
|
1U01CA164250-01
|
|
|
MELDRUM, DEIRDRE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Preclinical Development of iRGD for Pancreatic Cancer
|
1R43CA162766-01
|
$416,564
|
|
Slee, Deborah
|
ASPYRIAN THERAPEUTICS, INC.
|
|
Enhancing Treg Immune Reconstitution After Stem Cell Transplant
|
1R21CA149967-01A1
|
$325,834
|
|
BOLLARD, CATHERINE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Building capacity in food bank organizations for obesity prevention programs
|
5R21CA150977-02
|
|
|
Dave, Jayna
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving T-cell therapies for neuroblastoma
|
5R01CA142636-02
|
$447,592
|
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Obesity, H pylori and Risk of Barrett's Esophagus
|
5R01CA116845-05
|
$505,005
|
|
El-Serag, Hashem
|
BAYLOR COLLEGE OF MEDICINE
|
|
Force Sensing with Nanotubes
|
1R21CA152779-01A1
|
$204,233
|
|
Farrell, Brenda
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
3R01CA072038-14S1
|
$49,857
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-09
|
$1,924,347
|
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Advanced glycation end products and colorectal cancer risk in women
|
1R03CA156626-01
|
|
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Prevalence of CD24 epigenetic silencing in breast tumors and ERalpha status
|
1R03CA150027-01A1
|
$78,250
|
|
Kaipparettu, Benny
|
BAYLOR COLLEGE OF MEDICINE
|
|
BRIT1, A NOVEL HEPATOCELLULAR CARCINOMA TUMOR SUPPRESSOR
|
1R21CA161513-01
|
$205,277
|
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Heparanase Mechanisms in Brain-metastatic Breast Cancer
|
1R01CA160335-01
|
$297,350
|
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Characterization of prostatic stem cells and prostate cancer-initiating cells
|
3R00CA125937-05S1
|
$56,457
|
|
Xin, Li
|
BAYLOR COLLEGE OF MEDICINE
|
|
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
|
5R01CA142664-02
|
$308,958
|
|
YOTNDA, PATRICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
MECHANISMS OF SRC ACTIVATION AND ITS ROLE IN LATENT BONE METASTASIS OF BREAST AND
|
4R00CA151293-02
|
$241,529
|
|
ZHANG, XIANG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-16
|
$332,512
|
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
VEGFs in tumor lymphatic metastasis
|
4R01CA142262-03
|
$453,456
|
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-03
|
$706,671
|
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Stromal Regulation of Bone Metastasis
|
1U54CA163191-01
|
$925,878
|
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
|
5U01CA151925-02
|
$648,725
|
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Inhibition of angiogenesis by thrombospondin-1 (A2)
|
4R01CA130895-03
|
$348,364
|
|
LAWLER, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
5R01CA102142-07
|
$330,937
|
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-02
|
$350,219
|
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of NFAT and NFAT-Induced Genes in Carcinoma
|
5R01CA096710-08
|
$295,224
|
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting prostate cancer stem cells to delay prostate cancer progression
|
1R21CA153355-01A1
|
$189,225
|
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of Ultrasound-facilitated Formalin-fixed and Paraffin-embedded Tissue
|
5R44CA115041-04
|
$362,500
|
|
Zou, Nianxiang
|
BIO-QUICK CORPORATION
|
|
Development of a system (devices and protocols) to improve biospecimen preservati
|
1R21CA155478-01A1
|
$124,500
|
|
Hrudka, Brian
|
BIOSPECIMEN PROCUREMENT SOLUTIONS, INC.
|
|
Tobacco Control Research Branch Scientific and Technical Services Support
|
N02PC100043-002
|
$1,100,000
|
|
DORAN, KELLY
|
BLH TECHNOLOGIES, INC.
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-10
|
$320,196
|
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
Mechanisms of Action and Signaling by Steroid Hormone Antagonists
|
5R01CA101992-07
|
$252,463
|
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
BMP7 in melanoma niche morphogenesis and homeostasis
|
7R01CA138649-02
|
$328,581
|
|
HSU, MEI-YU
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Lung Sparing for SBRT with beam's-eye-view images and real time tumor tracking
|
1R21CA156068-01A1
|
$232,780
|
|
Berbeco, Ross
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
3U24CA114725-06S1
|
$309,562
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing disease and treatment response in colon cancer chemoprevention
|
5K05CA131504-04
|
$163,042
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
|
5R01CA129814-05
|
$318,505
|
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases
|
5R01CA131044-04
|
$350,078
|
|
COLSON, YOLONDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Analysis of Homing Receptors in Prostate Cancer
|
5R01CA118124-05
|
$274,238
|
|
DIMITROFF, CHARLES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Vaginal for this search: $1,100,747
|